Preventing the development and progression of diabetic kidney disease: Where do we stand?
- PMID: 29602760
- DOI: 10.1016/j.dsx.2018.03.012
Preventing the development and progression of diabetic kidney disease: Where do we stand?
Abstract
Diabetic kidney disease (DKD) is a major factor associated with increased cardiovascular (CV) and all-cause mortality and morbidity in patients with diabetes. Current standard therapy includes intensive management of hyperglycemia and blood pressure control with renin-angiotensin-aldosterone system (RAAS) blockers. Despite the implementation of this strategy, DKD remains the leading cause of end-stage renal disease (ESRD), mainly because of the increasing burden of diabetes mellitus. The aim of this review is to evaluate the available evidence, focusing on the benefit of current treatment in the development and progression of DKD.
Keywords: Blood pressure; Diabetes mellitus; Diabetic kidney disease; Glycemic control; RAAS inhibitors; SGLT-2 inhibitors.
Copyright © 2018 Diabetes India. Published by Elsevier Ltd. All rights reserved.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
